Baudax BioInc Ownership
BXRX Stock | USD 0.01 0.0003 2.91% |
Shares in Circulation | First Issued 2018-09-30 | Previous Quarter 4.9 M | Current Value 8 M | Avarage Shares Outstanding 853 K | Quarterly Volatility 2 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Baudax |
Baudax Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Baudax BioInc recorded a loss per share of 94.13. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 1st of December 2022. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company was incorporated in 2019 and is based in Malvern, Pennsylvania. Baudax Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 80 people. For more info on Baudax BioInc please contact Geraldine Henwood at 484 395 2440 or go to https://www.baudaxbio.com.Besides selling stocks to institutional investors, Baudax BioInc also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Baudax BioInc's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Baudax BioInc's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Baudax BioInc Quarterly Liabilities And Stockholders Equity |
|
Less than 1% of Baudax BioInc are currently held by insiders. Unlike Baudax BioInc's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Baudax BioInc's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Baudax BioInc's insider trades
Baudax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Baudax BioInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Baudax BioInc backward and forwards among themselves. Baudax BioInc's institutional investor refers to the entity that pools money to purchase Baudax BioInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Virtu Financial Llc | 2023-12-31 | 0.0 | Sittner & Nelson, Llc | 2023-09-12 | 0.0 | Blackrock Inc | 2023-12-31 | 0.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 0.0 | Xtx Topco Ltd | 2023-12-31 | 0.0 | Creative Planning Inc | 2023-09-30 | 0.0 | State Street Corporation | 2023-12-31 | 0.0 | Susquehanna International Group, Llp | 2023-12-31 | 0.0 | Wells Fargo & Co | 2023-12-31 | 0.0 | Jane Street Group, Llc | 2023-09-30 | 0.0 | Tower Research Capital Llc | 2023-12-31 | 0.0 |
Baudax BioInc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Baudax BioInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Baudax BioInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Baudax BioInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kim Yong Chan over three weeks ago Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 | ||
Altomari Alfred over a month ago Insider Trading | ||
Kim Yong Chan over six months ago Baudax BioInc exotic insider transaction detected |
Pair Trading with Baudax BioInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Baudax BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baudax BioInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Baudax Stock
0.75 | EVOK | Evoke Pharma | PairCorr |
0.61 | EWTX | Edgewise Therapeutics Financial Report 9th of May 2024 | PairCorr |
Moving against Baudax Stock
0.78 | HCWB | HCW Biologics | PairCorr |
0.78 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
0.74 | VKTX | Viking Therapeutics | PairCorr |
0.73 | OGN | Organon | PairCorr |
0.65 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Baudax BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Baudax BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Baudax BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Baudax BioInc to buy it.
The correlation of Baudax BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Baudax BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Baudax BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Baudax BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.